Arkolith/Insider Trading/ORKA/Form 4

Goncalves Joana

Chief Medical OfficerOruka Therapeutics, Inc. (ORKA) · full profile →Form 4 · filed Jun 15, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$551K
Net Open-Market Flow
-$551K
Transactions
8
6 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 15, 2026Option exercise(M)4K$6.84$24K37K
Jun 15, 2026Option exercise(M)4K$7.80$27K41K
Jun 15, 2026Sell(S)2K$68.38$112K39K
Jun 15, 2026Sell(S)5K$69.42$352K34K
Jun 15, 2026Sell(S)300$70.62$21K34K
Jun 15, 2026Sell(S)947$69.69$66K33K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 15, 2026Option exercise(M)4K—$0204K
Jun 15, 2026Option exercise(M)4K—$0175K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000907654-26-000063) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML